<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/aurobindo-pharma-gets-14-observations-from-the-usfda-for-hyderabad-plant-4640651.html"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-14T00:00:00+00:00"/>
    <meta property="og:title" content="Aurobindo Pharma gets 14 observations from the USFDA for Hyderabad plant"/>
    <meta property="og:description" content="The observations issued by the USFDA notifies the company's management of objectionable conditions at the inspected facility."/>
  </head>
  <body>
    <article>
      <h1>Aurobindo Pharma gets 14 observations from the USFDA for Hyderabad plant</h1>
      <h2>The observations issued by the USFDA notifies the company's management of objectionable conditions at the inspected facility.</h2>
      <address><time datetime="2019-11-14T00:00:00+00:00">14 Nov 2019</time> by <a rel="author">PTI</a></address>
      <p>Aurobindo Pharma has received 14 observations from the US health regulator for its Hyderabad-based plant, according to a regulatory filing.</p>
      <p>The US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at Pashamylaram, Hyderabad from November 4-13, Aurobindo Pharma said.</p>
      <p>"At the end of the inspection, we have been issued a Form 483 with 14 observations," it added.</p>
      <p>
        <a href="https://www.moneycontrol.com/news/business/javascript:;">Close</a>
      </p>
      <p>The company believes that none of the observations are related to data integrity issues and, it will respond to the USFDA within the stipulated timeline, Aurobindo Pharma said.</p>
      <p>The observations issued by the USFDA notifies the company's management of objectionable conditions at the inspected facility.<a href="https://www.moneycontrol.com/promos/pro.php">Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights &amp; analysis For more information, check out the Moneycontrol website or mobile app.</a></p>
    </article>
  </body>
</html>